TCL Archive In Brief: Three Centers Win Comprehensive Designation; Hiatt Named Deputy Director, NCI Cancer Control October 31, 1997
TCL Archive Amgen Web Site For Patients Goes Dark After Story In The Cancer Letter. November 16, 2007
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive In Brief: Increasing Survival Through Adjuvant Therapy Seen As Adding To Cost Of Care October 24, 1975
